Dr. O'Dwyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-5823Fax+1 585-273-1051- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2006
Clinical Center at the National Institutes of HealthInternship, Internal Medicine, 2003 - 2004
University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
NY State Medical License 2007 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients Start of enrollment: 2014 Mar 01
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia Start of enrollment: 2019 Dec 06
Publications & Presentations
PubMed
- 6 citationsA phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.Jane L. Liesveld, Andrea Baran, Mitra Azadniv, Haley Misch, Katherine Nedrow, Michael W. Becker, Kah Poh Loh, Kristen M. O'Dwyer, Jason H. Mendler> ;Leukemia Research. 2022 Jan 1
- 3 citationsPortable Medical Orders and End of Life Measures in Acute Myeloid Leukemia and Myelodysplastic Syndromes.Marissa Locastro, Andrea Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen M. O'Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi M. Kluger,...> ;Blood Advances. 2021 Sep 15
- 248 citationsKTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 studyBijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachani...> ;Lancet. 2021 Aug 7
- Join now to see all
Abstracts/Posters
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Kristen Marie O'Dwyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...Kristen Marie O'Dwyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Combo Treatment Sans Chemotherapy Effective for Ph+ ALL ElderlyDecember 12th, 2023
Hospital Affiliations
Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
